Sernova Biotherapeutics Inc
SEOVF
$0.10
$0.003.43%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 45.08% | 56.41% | 52.66% | 53.71% | 48.35% |
| Total Depreciation and Amortization | -40.14% | -38.73% | -37.86% | -9.43% | -4.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 119.55% | 69.09% | 67.31% | -60.19% | -57.97% |
| Change in Net Operating Assets | -25.74% | -65.26% | -84.52% | -76.13% | -61.38% |
| Cash from Operations | 65.12% | 63.94% | 44.40% | 45.94% | 42.98% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -72.34% |
| Cash from Investing | -99.51% | -99.73% | -99.78% | -99.96% | -72.32% |
| Total Debt Issued | -62.54% | -- | -- | -- | -- |
| Total Debt Repaid | -2,271.67% | 58.22% | 33.23% | 13.14% | 0.88% |
| Issuance of Common Stock | 30.91% | -70.39% | -94.90% | 32,893.67% | 32,893.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 84.87% | -19.67% | 489.87% | -144.54% | -133.86% |
| Cash from Financing | -51.91% | 22.59% | -2.39% | 3,434.82% | 4,611.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.40% | 87.32% | -102.35% | 62.93% | 86.03% |